Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Idorsia (IDIA.SW) has a market cap of $0.31 billion USD. According to our data, Idorsia is ranked No.6496 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.31 B |
61.77%
|
| Dec 30, 2024 | $0.19 B |
-61.12%
|
| Dec 29, 2023 | $0.49 B |
-84.25%
|
| Dec 30, 2022 | $3.09 B |
-28.00%
|
| Dec 30, 2021 | $4.29 B |
-26.96%
|
| Dec 30, 2020 | $5.87 B |
-13.62%
|
| Dec 30, 2019 | $6.80 B |
84.59%
|
| Dec 28, 2018 | $3.68 B |
-36.27%
|
| Dec 29, 2017 | $5.78 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Rogers Corporation
ROG
|
$1.00 B |
0.000 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
| Market Cap | = | IDIA.SW Stock Price | * | IDIA.SW Shares Outstanding |
| = | $1.37 | * | 0.22 B | |
| = | $0.31 B |